Planet 13 Holdings INC 8-K filings

Planet 13 reported a Q4 2023 revenue of $23.0 million and a net loss of $14.3 million, which included a non-cash impairment loss of $7.2 million, while achieving positive adjusted EBITDA of $1.3 million.

Planet 13 Holdings has announced its annual shareholder meeting will be held on June 11, 2024, with a record date of April 12, 2024.

Planet 13 Holdings Inc. successfully closed a public offering, raising approximately $11.3 million through the sale of units consisting of common stock and warrants.

Planet 13 Holdings has commenced an underwritten public offering of units and is providing additional disclosures related to its acquisition of VidaCann and the sale of its Florida license.

Planet 13 Holdings Inc. released unaudited preliminary financial results for Q4 and full year 2023, highlighting positive adjusted EBITDA despite a challenging market.

Planet 13 Holdings Inc. announces strategic leadership changes, including the appointment of a new Chief Administrative Officer and a new board member, to support its expansion and growth initiatives.

Planet 13 Holdings will restate its financial statements for 2021, 2022 and 2023 due to a believed misappropriation of approximately $22 million by its investment advisor, El Capitan Advisors.

Planet 13 is pursuing legal action after approximately $16.5 million in funds managed by El Capitan Advisors were allegedly misappropriated.

Planet 13 Holdings Inc. has announced its 2024 annual shareholder meeting will be held on June 11, 2024, and has set deadlines for shareholder proposals and director nominations.

Planet 13 Holdings Inc. has entered into an agreement to sell its Florida medical marijuana treatment center license for $9 million in cash, a key step in its acquisition of VidaCann, LLC.